BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:45 PM
 | 
Feb 03, 2010
 |  BC Extra  |  Company News

FDA approves Oleptro

FDA approved an NDA from Labopharm Inc. (TSX:DDS; NASDAQ:DDSS) for Oleptro trazodone extended-release tablets to treat major depressive disorder (MDD). Oleptro's label includes a black box warning about the...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >